RELAPSE MULTIPLE MYELOMA

Clinical trials for RELAPSE MULTIPLE MYELOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSE MULTIPLE MYELOMA trials appear

Sign up with your email to follow new studies for RELAPSE MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 2

New hope for Hard-to-Treat myeloma: CAR T-Cells join forces with daratumumab

Disease control Not yet recruiting

This early-phase study tests a new treatment called FT836 CAR T-cell therapy combined with daratumumab in 12 adults with multiple myeloma that has returned or not responded to at least three prior treatments. The main goal is to check safety and find the right dose. Participants …

Matched conditions: RELAPSE MULTIPLE MYELOMA

Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control

Last updated May 17, 2026 04:29 UTC

RELAPSE MULTIPLE MYELOMA

Get alerted when new RELAPSE MULTIPLE MYELOMA trials appear

New hope for Hard-to-Treat myeloma: CAR T-Cells join forces with daratumumab